加强埃斯瓦蒂尼糖尿病和高血压的基层医疗:全国性整群随机对照试验研究方案
该研究为在埃斯瓦蒂尼开展的整群随机对照试验,将84家基层医疗机构按1:1:1随机分为三组,评估两种社区医疗服务模式与对照组的差异。主要终点为40岁及以上糖尿病或高血压患者的平均糖化血红蛋白和收缩压,将通过家庭调查评估,并开展成本效果、协同流行病及实施过程研究。
要点
- 84家基层医疗机构按1:1:1随机分为三组,比较两种社区服务模式与对照。
- 干预组由农村健康促进员入户筛查、咨询并转诊至诊所或社区分发点。
- 主要终点为40岁及以上糖尿病或高血压患者的平均HbA1c和收缩压。
核心结论
- 该研究旨在协助埃斯瓦蒂尼政府选择最有效的糖尿病和高血压服务提供模式,所获证据可能对撒哈拉以南非洲更广泛地区的政策制定者有用。
研究设计与样本
- 整群随机对照试验,设两个干预组和一个对照组,随机单位为基层医疗机构及其下属全部农村健康促进员(RHM)及对应服务区域。
- 共84家基层医疗机构按1:1:1比例随机分配至三个研究组。
主要发现
- 第一干预组在诊所和社区层面实施差异化服务提供(DSD)模式,旨在改善糖尿病或高血压客户的治疗接受和依从性。
- 第二干预组将既往针对人类免疫缺陷病毒感染者的社区分发点(CDP)服务扩展至糖尿病或高血压客户,允许其在社区取药并接受常规护士主导的随访。
- 两个干预组中,RHM定期入户、筛查高危客户、提供个性化咨询并将客户转诊至基层诊所或最近的CDP。
- 对照组基层诊所提供糖尿病和高血压护理服务,但不涉及RHM、不实施DSD模式或CDP。
- 主要终点为40岁及以上糖尿病或高血压成人中分别评估的平均糖化血红蛋白(HbA1c)和收缩压,通过RHM服务区域的家庭调查评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes and hypertension are increasingly important population health challenges in Eswatini. Prior to this project, healthcare for these conditions was primarily provided through physician-led teams at tertiary care facilities and accessed by only a small fraction of people living with diabetes or hypertension. This trial tests and evaluates two community-based healthcare service models implemented at the national level, which involve health care personnel at primary care facilities and utilize the country's public sector community health worker cadre (the rural health motivators [RHMs]) to help generate demand for care. METHODS: This study is a cluster-randomized controlled trial with two treatment arms and one control arm. The unit of randomization is a primary healthcare facility along with all RHMs (and their corresponding service areas) assigned to the facility. A total of 84 primary healthcare facilities were randomized in a 1:1:1 ratio to the three study arms. The first treatment arm implements differentiated service delivery (DSD) models at the clinic and community levels with the objective of improving treatment uptake and adherence among clients with diabetes or hypertension. In the second treatment arm, community distribution points (CDPs), which previously targeted clients living with human immunodeficiency virus, extend their services to clients with diabetes or hypertension by allowing them to pick up medications and obtain routine nurse-led follow-up visits in their community rather than at the healthcare facility. In both treatment arms, RHMs visit households regularly, screen clients at risk, provide personalized counseling, and refer clients to either primary care clinics or the nearest CDP. In the control arm, primary care clinics provide diabetes and hypertension care services but without the involvement of RHMs and the implementation of DSD models or CDPs. The primary endpoints are mean glycated hemoglobin (HbA1c) and systolic blood pressure among adults aged 40 years and older living with diabetes or hypertension, respectively. These endpoints will be assessed through a household survey in the RHM service areas. In addition to the health impact evaluation, we will conduct studies on cost-effectiveness, syndemics, and the intervention's implementation processes. DISCUSSION: This study has the ambition to assist the Eswatini government in selecting the most effective delivery model for diabetes and hypertension care. The evidence generated with this national-level cluster-randomized controlled trial may also prove useful to policy makers in the wider Sub-Saharan African region. TRIAL REGISTRATION: NCT04183413. Trial registration date: December 3, 2019.
引用
- Theilmann M, Ginindza N, Myeni J, et al. Strengthening primary care for diabetes and hypertension in Eswatini: study protocol for a nationwide cluster-randomized controlled trial. Trials. 2023. PMID: 36949485. doi:10.1186/s13063-023-07096-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。